Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Peng, Ping ^a   Lian, Jiangfang ^a   Huang, R Stephanie ^b   Xu, Limin ^a   Huang, Yi ^a   Ba, Yanna ^a   Yang, Xi ^a   Huang, Xiaoyan ^a   Dong, Changzhen ^a   Zhang, Lina ^a   Ye, Meng ^a   Zhou, Jianqing ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MOLECULAR MOTOR;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; DRUG RESPONSE; ETHNIC DIFFERENCE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; KIF6 GENE; META ANALYSIS; PHARMACOGENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ALLELES; CASE-CONTROL STUDIES; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KINESIN; MALE; SEX FACTORS; TREATMENT OUTCOME;

EID: 84870924855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050126     Document Type: Article

References (39)

1. Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, et al. (2007) A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 27: 2030-2036.
2. Nolan DK, Sutton B, Haynes C, Johnson J, Sebek J, et al. (2012) Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. BMC Genet 13: 12.
3. Wang AZ, Li L, Zhang B, Shen GQ, Wang QK, (2011) Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. Ann Hum Genet 75: 475-482.
4. Butterworth AS, Braund P, S., Farrall M, Hardwick RJ, Saleheen D, et al. (2011) Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 7: e1002260.
5. Peden JF, Farrall M, (2011) Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet 20: R198-205.
6. Shiffman D, Chasman DI, Zee RY, Iakoubova OA, Louie JZ, et al. (2008) A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. J Am Coll Cardiol 51: 444-448.
7. Iakoubova O, Shepherd J, Sacks F, (2008) Association of the 719Arg variant of KIF6 with both increased risk of coronary events and with greater response to statin therapy. J Am Coll Cardiol 51: 2195; author reply 2195-2196.
8. Shiffman D, Sabatine MS, Louie JZ, Kirchgessner TG, Iakoubova OA, et al. (2010) Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. Am J Cardiol 105: 1300-1305.
9. Bare LA, Ruiz-Narvaez EA, Tong CH, Arellano AR, Rowland CM, et al. (2010) Investigation of KIF6 Trp719Arg in a case-control study of myocardial infarction: a Costa Rican population. PLoS One 5.
10. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, et al. (2008) Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol 51: 435-443.
11. Williams P, Pendyala L, Superko R, (2011) Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease. BMC Med Genet 12: 42.
12. Li Y, Iakoubova OA, Shiffman D, Devlin JJ, Forrester JS, et al. (2010) KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy. Am J Cardiol 106: 994-998.
13. Hopewell JC, Parish S, Clarke R, Armitage J, Bowman L, et al. (2011) No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study. J Am Coll Cardiol 57: 2000-2007.
14. Shiffman D, O'Meara ES, Bare LA, Rowland CM, Louie JZ, et al. (2008) Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 28: 173-179.
15. Iakoubova OA, Robertson M, Tong CH, Rowland CM, Catanese JJ, et al. (2010) KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. Eur J Cardiovasc Prev Rehabil 17: 455-461.
16. Li Y, Sabatine MS, Tong CH, Ford I, Kirchgessner TG, et al. (2011) Genetic variants in the KIF6 region and coronary event reduction from statin therapy. Hum Genet 129: 17-23.
17. Ridker PM, MacFadyen JG, Glynn RJ, Chasman DI, (2011) Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention. Circ Cardiovasc Genet 4: 312-317.
18. Stewart AF, Dandona S, Chen L, Assogba O, Belanger M, et al. (2009) Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. J Am Coll Cardiol 53: 1471-1472.
19. Luke MM, Lalouschek W, Rowland CM, Catanese JJ, Bolonick JI, et al. (2009) Polymorphisms associated with both noncardioembolic stroke and coronary heart disease: vienna stroke registry. Cerebrovasc Dis 28: 499-504.
20. Cheng Y, Wei Y, Li W, Chen J, Zhang W, et al. (2011) Associations between oxidized-lipoprotein receptor 1 G501C and 3′-UTR-C188T polymorphisms and coronary artery disease: a meta-analysis. Cardiology 119: 90-95.
21. Liu Y, Niu W, Wu Z, Su X, Chen Q, et al. (2012) Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis. PLoS One 7: e31406.
22. Clarke R, Bennett DA, Parish S, Verhoef P, Dotsch-Klerk M, et al. (2012) Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med 9: e1001177.
23. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283: 2008-2012.
24. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634.
25. Higgs ZC, Macafee DA, Braithwaite BD, Maxwell-Armstrong CA, (2005) The Seldinger technique: 50 years on. Lancet 366: 1407-1409.
26. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59: 607-609.
27. Yu J, Huang J, Liang Y, Qin B, He S, et al. (2011) Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China. Lipids Health Dis 10: 200.
28. Gabriel S, Ziaugra L, Tabbaa D, (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter 2: Unit 2 12.
29. Li Y, Sabatine MS, Tong CH, Ford I, Kirchgessner TG, et al. (2010) Genetic variants in the KIF6 region and coronary event reduction from statin therapy. Hum Genet 129: 17-23.
30. Excoffier L, Lischer HE, (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10: 564-567.
31. Sham PC, Curtis D, (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59: 97-105.
32. Dupont WD, Plummer WD Jr, (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11: 116-128.
33. Bhanushali AA, Contractor A, Shah VT, Das BR, (2011) Investigation of KIF6 Trp719Arg in a case-control study of coronary artery disease in Western Indians. Genet Test Mol Biomarkers 15: 883-886.
34. Assimes TL, Holm H, Kathiresan S, Reilly MP, Thorleifsson G, et al. (2010) Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol 56: 1552-1563.
35. Wen-shen Xu S-kY, Hui YANG, XIA L-y, (2011) Association of KIF6 Gene Rs20455 Polymorphisms with Coronary Heart Disease and The Levels of Serum Lipids in Han Nationality from Northern China. Molecular Cardiology of China 11: 5.
36. Akao H, Polisecki E, Kajinami K, Trompet S, Robertson M, et al. (2012) KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly. Atherosclerosis 220: 456-462.
37. Iakoubova OA, Sabatine MS, Rowland CM, Tong CH, Catanese JJ, et al. (2008) Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol 51: 449-455.
38. Wang L, Yanuck D, Beecham A, Gardener H, Slifer S, et al. (2011) A candidate gene study revealed sex-specific association between the OLR1 gene and carotid plaque. Stroke 42: 588-592.
39. Zhou J, Huang Y, Huang RS, Wang F, Xu L, et al. (2012) A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect. Thromb Res 130: 602-606.